The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer. [PDF]
Chiu CF +5 more
europepmc +1 more source
Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer. [PDF]
White BM +11 more
europepmc +1 more source
Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation. [PDF]
Wu Y +11 more
europepmc +1 more source
CHK1 inhibition overcomes gemcitabine resistance in non-small cell lung cancer cell A549. [PDF]
Ke ZY +7 more
europepmc +1 more source
The Natural Compound CalebinA Suppresses Gemcitabine Resistance and Tumor Progression by Inhibiting Angiogenesis and Invasion Through NF-κB Signaling in Pancreatic Cancer. [PDF]
Eguchi Y +16 more
europepmc +1 more source
Targeting ALG3/FOXD1/BNIP3 Axis Prevents Mitophagy and Gemcitabine Resistance of Nasopharyngeal Carcinoma. [PDF]
Wang Z +7 more
europepmc +1 more source
O-GlcNAcylation with ubiquitination stabilizes METTL3 to promoting HMGB1 degradation to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic cancer. [PDF]
Wang Q +10 more
europepmc +1 more source
Mathematical strategies for predicting resistant subpopulations from scRNAseq data of a PANC-1 3D tissue model: Insight into gemcitabine resistance and TGFB1-induced invasion and EMT. [PDF]
Caliskan A +5 more
europepmc +1 more source
Bioinformatics-based screening of key genes associated with gemcitabine resistance in advanced pancreatic ductal adenocarcinoma. [PDF]
Hu K, Hasegawa K, Zhou G.
europepmc +1 more source
Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways. [PDF]
Li Y +9 more
europepmc +1 more source

